A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C B Sangro, C Gomez-Martin, M de la Mata, M Iñarrairaegui, E Garralda, ... Journal of hepatology 59 (1), 81-88, 2013 | 1038 | 2013 |
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death L Galluzzi, I Vitale, S Warren, S Adjemian, P Agostinis, AB Martinez, ... Journal for immunotherapy of cancer 8 (1), 2020 | 803 | 2020 |
Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy Y Ma, L Aymeric, C Locher, SR Mattarollo, NF Delahaye, P Pereira, ... Journal of Experimental Medicine 208 (3), 491-503, 2011 | 394 | 2011 |
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression L Corrales, D Ajona, S Rafail, JJ Lasarte, JI Riezu-Boj, JD Lambris, ... The Journal of Immunology 189 (9), 4674-4683, 2012 | 297 | 2012 |
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-γ-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by … N Casares, L Arribillaga, P Sarobe, J Dotor, A Lopez-Diaz de Cerio, ... The Journal of Immunology 171 (11), 5931-5939, 2003 | 256 | 2003 |
Transmission of hepatitis C virus infection to tree shrews ZC Xie, JI Riezu-Boj, JJ Lasarte, J Guillen, JH Su, MP Civeira, J Prieto Virology 244 (2), 513-520, 1998 | 250 | 1998 |
Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins P Sarobe, JJ Lasarte, N Casares, A López-Díaz de Cerio, E Baixeras, ... Journal of virology 76 (10), 5062-5070, 2002 | 223 | 2002 |
Topical application of a peptide inhibitor of transforming growth factor-β1 ameliorates bleomycin-induced skin fibrosis B Santiago, I Gutierrez-Cañas, J Dotor, G Palao, JJ Lasarte, J Ruiz, ... Journal of Investigative Dermatology 125 (3), 450-455, 2005 | 200 | 2005 |
Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses P Sarobe, JJ Lasarte, A Zabaleta, L Arribillaga, A Arina, I Melero, ... Journal of virology 77 (20), 10862-10871, 2003 | 190 | 2003 |
A combined PD-1/C5a blockade synergistically protects against lung cancer growth and metastasis D Ajona, S Ortiz-Espinosa, H Moreno, T Lozano, MJ Pajares, J Agorreta, ... Cancer discovery 7 (7), 694-703, 2017 | 189 | 2017 |
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression C Segovia, E San Jose-Eneriz, E Munera-Maravilla, ... Nature medicine 25 (7), 1073-1081, 2019 | 152 | 2019 |
Upregulation of indoleamine 2, 3-dioxygenase in hepatitis C virus infection E Larrea, JI Riezu-Boj, L Gil-Guerrero, N Casares, R Aldabe, P Sarobe, ... Journal of virology 81 (7), 3662-3666, 2007 | 152 | 2007 |
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies E San José-Enériz, X Agirre, O Rabal, A Vilas-Zornoza, JA Sanchez-Arias, ... Nature communications 8 (1), 15424, 2017 | 145 | 2017 |
A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury IJ Ezquerro, JJ Lasarte, J Dotor, I Castilla-Cortazar, M Bustos, I Peñuelas, ... Cytokine 22 (1-2), 12-20, 2003 | 141 | 2003 |
A synthetic peptide from transforming growth factor-β1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats N Hermida, B López, A González, J Dotor, JJ Lasarte, P Sarobe, ... Cardiovascular research 81 (3), 601-609, 2009 | 136 | 2009 |
A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice N Casares, F Rudilla, L Arribillaga, D Llopiz, JI Riezu-Boj, T Lozano, ... The Journal of Immunology 185 (9), 5150-5159, 2010 | 130 | 2010 |
The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo JJ Lasarte, N Casares, M Gorraiz, S Hervás-Stubbs, L Arribillaga, ... The Journal of Immunology 178 (2), 748-756, 2007 | 127 | 2007 |
Poly (anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation I Tamayo, JM Irache, C Mansilla, J Ochoa-Repáraz, JJ Lasarte, ... Clinical and Vaccine Immunology 17 (9), 1356-1362, 2010 | 124 | 2010 |
Is plasma cardiotrophin-1 a marker of hypertensive heart disease? B López, A González, JJ Lasarte, P Sarobe, F Borrás, A Díaz, J Barba, ... Journal of hypertension 23 (3), 625-632, 2005 | 124 | 2005 |
Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen H Kobayashi, R Omiya, M Ruiz, E Huarte, P Sarobe, JJ Lasarte, M Herraiz, ... Clinical cancer research 8 (10), 3219-3225, 2002 | 118 | 2002 |